Square Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SQUARE PHARMS, and what generic and branded alternatives to SQUARE PHARMS drugs are available?
SQUARE PHARMS has five approved drugs.
Summary for Square Pharms
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Square Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Square Pharms | VALSARTAN | valsartan | TABLET;ORAL | 205347-004 | Apr 9, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Square Pharms | ACYCLOVIR | acyclovir | TABLET;ORAL | 209366-001 | Oct 7, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Square Pharms | VALSARTAN | valsartan | TABLET;ORAL | 205347-001 | Apr 9, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Square Pharms | VALSARTAN | valsartan | TABLET;ORAL | 205347-003 | Apr 9, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Square Pharms | MIRTAZAPINE | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 205798-003 | Jun 1, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Square Pharms | ARIPIPRAZOLE | aripiprazole | TABLET, ORALLY DISINTEGRATING;ORAL | 090165-001 | Aug 28, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Square Pharms | MIRTAZAPINE | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 205798-001 | Jun 1, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
